- Home
- LUCY
as 06-06-2025 4:00pm EST
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | MIAMI |
| Market Cap: | 8.9M | IPO Year: | 2022 |
| Target Price: | N/A | AVG Volume (30 days): | 2.5M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.95 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.57 - $15.88 | Next Earning Date: | 05-13-2025 |
| Revenue: | $1,707,470 | Revenue Growth: | 22.75% |
| Revenue Growth (this year): | 367.48% | Revenue Growth (next year): | 166.67% |
Latest Innovative Eyewear Inc. News
LUCY Breaking Stock News: Dive into LUCY Ticker-Specific Updates for Smart Investing
PR Newswire
8 days ago
Innovative Eyewear, Inc. Announces Exciting New Features for the Lucyd ChatGPT App
Simply Wall St.
21 days ago
Innovative Eyewear First Quarter 2025 Earnings: US$0.72 loss per share (vs US$3.04 loss in 1Q 2024)
MT Newswires
23 days ago
Investors Evaluate Impact of Inflation Report as US Futures Edge Higher Pre-Bell
Benzinga
23 days ago
What's Going On With Innovative Eyewear Stock On Wednesday?
MT Newswires
23 days ago
Top Premarket Gainers
PR Newswire
24 days ago
Innovative Eyewear Inc. Reports Q1 2025 Unaudited Financial Results
PR Newswire
a month ago
Innovative Eyewear Partners with Eye Recommend, Expanding Smart Eyewear Access Across 600+ Independent Optometry Stores
PR Newswire
a month ago
Innovative Eyewear Launches Reebok® Smart Eyewear
Compare LUCY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LUCY Innovative Eyewear Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.